FDA approves ROXRO PHARMA’s SPRIX Nasal Spray

FDA approves ROXRO PHARMA’s SPRIX Nasal Spray
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.

Read more on News-Medical-Net

More Meth Drug Addiction Info:

• Ketorolac substitute for toradol
• USA FDA Bans two Dietary Weight-Loss Supplements | Weight Loss …
• Valerian – Still Lacks FDA Approval as Hypertension Treatment …
• Ketorolac of toradol
• Neurontin and narcolepsy | Mikes.spb.su table
• Buy generic ketorolac 10mg | Kirilenko.msk.su med blog
• Ketorolac tromethamine toradol injection
• Buy ketorolac generic | Ferkina.msk.su table
• ROXRO Announces FDA Approval of SPRIX(TM) | Pharmacy News EU
• Consensus Panel Recommendations: PHARMACOLOGICAL TREATMENTS …